Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.47−0.39 (-1.35%)
Close on Nov 17, 2026Market cap $162.27BP/E 37.5Yield 6.04%
Pfizer shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Pfizer's shares outstanding was 5.70B at Jun 28, 2026. For fiscal 2025 it was 5.71B, up 0.2% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is 8.07B in fiscal 2010.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.71B | +0.2% |
| FY2024 | Dec 31, 2024 | 5.70B | -0.2% |
| FY2023 | Dec 31, 2023 | 5.71B | -0.4% |
| FY2022 | Dec 31, 2022 | 5.73B | +0.4% |
| FY2021 | Dec 31, 2021 | 5.71B | +1.3% |
| FY2020 | Dec 31, 2020 | 5.63B | -0.8% |
| FY2019 | Dec 31, 2019 | 5.67B | -5.1% |
| FY2018 | Dec 31, 2018 | 5.98B | -1.3% |
| FY2017 | Dec 31, 2017 | 6.06B | -1.6% |
| FY2016 | Dec 31, 2016 | 6.16B | -1.6% |
| FY2015 | Dec 31, 2015 | 6.26B | -2.6% |
| FY2014 | Dec 31, 2014 | 6.42B | -6.8% |
| FY2013 | Dec 31, 2013 | 6.89B | -8.2% |
| FY2012 | Dec 31, 2012 | 7.51B | -4.6% |
| FY2011 | Dec 31, 2011 | 7.87B | -2.5% |
| FY2010 | Dec 31, 2010 | 8.07B | +14.6% |
| FY2009 | Dec 31, 2009 | 7.04B | +4.4% |
| FY2008 | Dec 31, 2008 | 6.75B | -2.7% |
| FY2007 | Dec 31, 2007 | 6.94B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 28, 2026 | 5.70B | -0.1% |
| Q1 FY2026 | Mar 29, 2026 | 5.73B | +0.4% |
| Q4 FY2025 | Dec 31, 2025 | 5.72B | +0.3% |
| Q3 FY2025 | Sep 28, 2025 | 5.71B | +0.2% |
| Q2 FY2025 | Jun 29, 2025 | 5.71B | +0.2% |
| Q1 FY2025 | Mar 30, 2025 | 5.71B | +0.2% |
| Q4 FY2024 | Dec 31, 2024 | 5.70B | +0.2% |
| Q3 FY2024 | Sep 29, 2024 | 5.71B | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | 5.70B | -0.3% |
| Q1 FY2024 | Mar 31, 2024 | 5.70B | -0.5% |
| Q4 FY2023 | Dec 31, 2023 | 5.69B | -0.9% |
| Q3 FY2023 | Oct 1, 2023 | 5.65B | -1.3% |
| Q2 FY2023 | Jul 2, 2023 | 5.71B | +0.0% |
| Q1 FY2023 | Apr 2, 2023 | 5.73B | -0.5% |
| Q4 FY2022 | Dec 31, 2022 | 5.75B | -0.4% |
| Q3 FY2022 | Oct 2, 2022 | 5.72B | -0.1% |
| Q2 FY2022 | Jul 3, 2022 | 5.71B | +0.6% |
| Q1 FY2022 | Apr 3, 2022 | 5.76B | +1.7% |
| Q4 FY2021 | Dec 31, 2021 | 5.77B | +1.9% |
| Q3 FY2021 | Oct 3, 2021 | 5.72B | +1.6% |
| Q2 FY2021 | Jul 4, 2021 | 5.68B | +1.1% |
| Q1 FY2021 | Apr 4, 2021 | 5.66B | +0.9% |
| Q4 FY2020 | Dec 31, 2020 | 5.66B | +0.6% |
| Q3 FY2020 | Sep 27, 2020 | 5.63B | -0.3% |
| Q2 FY2020 | Jun 28, 2020 | 5.62B | -0.9% |
| Q1 FY2020 | Mar 29, 2020 | 5.61B | -2.4% |
| Q4 FY2019 | Dec 31, 2019 | 5.63B | -4.8% |
| Q3 FY2019 | Sep 29, 2019 | 5.65B | -5.6% |
| Q2 FY2019 | Jun 30, 2019 | 5.67B | -4.7% |
| Q1 FY2019 | Mar 31, 2019 | 5.75B | -5.1% |
| Q4 FY2018 | Dec 31, 2018 | 5.91B | -2.4% |
| Q3 FY2018 | Sep 30, 2018 | 5.99B | -0.9% |
| Q2 FY2018 | Jul 1, 2018 | 5.95B | -1.4% |
| Q1 FY2018 | Apr 1, 2018 | 6.06B | -0.6% |
| Q4 FY2017 | Dec 31, 2017 | 6.06B | -0.8% |
| Q3 FY2017 | Oct 1, 2017 | 6.04B | -1.8% |
| Q2 FY2017 | Jul 2, 2017 | 6.04B | – |
| Q1 FY2017 | Apr 2, 2017 | 6.09B | – |
| Q4 FY2016 | Dec 31, 2016 | 6.11B | – |
| Q3 FY2016 | Oct 2, 2016 | 6.15B | – |
See a number that looks wrong?